Galectin Therapeutics Inc
GALT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133416
In the last 90 days, Galectin Therapeutics Inc insiders filed 0 open-market purchases and 1 sale; 98 institutions reported holding it in 13F filings for Q2 2026, worth $72.2M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Galectin Therapeutics Inc changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 86 | 1 | 84 | −1 |
| Shares | 10.5M | 6.00K | 10.3M | −192.4K (−1.8%) |
| Value | $22.2M | $12.7K | $43.9M | +$21.7M (+97.9%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Galectin Therapeutics Inc at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 87,094 | $369.0K | 0.03% |
| Charles Schwab Investment Management Inc | 44,989 | $190.5K | 0.00% |
| Virtu Financial LLC | 38,968 | $165.0K | 0.01% |
| Lido Advisors, LLC | 36,327 | $153.8K | 0.00% |
| Jefferies Financial Group Inc. | 17,300 | $73.3K | 0.00% |
| Two Sigma Investments, LP | 16,647 | $70.5K | 0.00% |
| Hudson Bay Capital Management LP | 14,826 | $62.8K | 0.00% |
| Archer Investment Corp | 11,000 | $46.6K | 0.01% |
| Creative Planning | 10,385 | $44.0K | 0.00% |
| Atwood & Palmer Inc | 10,000 | $42.4K | 0.00% |
| Rockefeller Capital Management L.P. | 4,386 | $18.6K | 0.00% |
| Hantz Financial Services, Inc. | 2,083 | $9.00K | 0.00% |
| Signaturefd, LLC | 1,549 | $6.56K | 0.00% |
| SRS Capital Advisors, Inc. | 52 | $220 | 0.00% |
| Optiver Holding B.V. | 18 | $76 | 0.00% |
Sold out (16)
Institutions that held Galectin Therapeutics Inc at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Soltis Investment Advisors LLC | 140,750 | $297.0K |
| HRT Financial LP | 77,200 | $162.0K |
| XTX Topco Ltd | 42,805 | $90.3K |
| Beacon Capital Management, LLC | 23,905 | $50.4K |
| Point72 Asia (Singapore) Pte. Ltd. | 14,589 | $30.8K |
| Tang Capital Management LLC | 12,913 | $27.2K |
| AQR Capital Management LLC | 12,378 | $26.1K |
| Berkshire Money Management, Inc. | 11,349 | $23.9K |
| Raymond James Financial Inc | 10,550 | $22.3K |
| Dynamic Advisor Solutions LLC | 10,000 | $21.1K |
| Tower Research Capital LLC (TRC) | 4,819 | $10.2K |
| Cubist Systematic Strategies, LLC | 561 | $1.18K |
| Mirae Asset Global ETFs Holdings Ltd. | 374 | $789 |
| Point72 (DIFC) Ltd | 187 | $395 |
| SBI Securities Co., Ltd. | 5 | $11 |
| Essential Partners LLC | 1 | $2 |
Not filed for Q3 2025 yet (1)
Institutions that held Galectin Therapeutics Inc at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Financial Gravity Companies, Inc. | 5,997 | $12.7K |